IT1284876B1 - Hcg come inibitore della collagenasi - Google Patents

Hcg come inibitore della collagenasi

Info

Publication number
IT1284876B1
IT1284876B1 IT96RM000566A ITRM960566A IT1284876B1 IT 1284876 B1 IT1284876 B1 IT 1284876B1 IT 96RM000566 A IT96RM000566 A IT 96RM000566A IT RM960566 A ITRM960566 A IT RM960566A IT 1284876 B1 IT1284876 B1 IT 1284876B1
Authority
IT
Italy
Prior art keywords
hcg
collagenase inhibitor
collagenase
inhibitor
Prior art date
Application number
IT96RM000566A
Other languages
English (en)
Inventor
Adriana Albini
Giorgia Orlengo
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of ITRM960566A0 publication Critical patent/ITRM960566A0/it
Priority to IT96RM000566A priority Critical patent/IT1284876B1/it
Priority to JP50755698A priority patent/JP3996952B2/ja
Priority to PCT/EP1997/004053 priority patent/WO1998005353A1/en
Priority to DK97934545T priority patent/DK0920330T3/da
Priority to CA002262582A priority patent/CA2262582C/en
Priority to IL128399A priority patent/IL128399A/en
Priority to AT97934545T priority patent/ATE228372T1/de
Priority to PT97934545T priority patent/PT920330E/pt
Priority to AU37711/97A priority patent/AU732972B2/en
Priority to US09/242,099 priority patent/US6444639B2/en
Priority to EP97934545A priority patent/EP0920330B1/en
Priority to DE69717463T priority patent/DE69717463T2/de
Priority to ES97934545T priority patent/ES2183205T3/es
Priority to ARP970103577A priority patent/AR009013A1/es
Publication of ITRM960566A1 publication Critical patent/ITRM960566A1/it
Application granted granted Critical
Publication of IT1284876B1 publication Critical patent/IT1284876B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT96RM000566A 1996-08-07 1996-08-07 Hcg come inibitore della collagenasi IT1284876B1 (it)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IT96RM000566A IT1284876B1 (it) 1996-08-07 1996-08-07 Hcg come inibitore della collagenasi
AT97934545T ATE228372T1 (de) 1996-08-07 1997-07-25 Hcg und derivate als matrixmetalloprotease- inhibitoren
AU37711/97A AU732972B2 (en) 1996-08-07 1997-07-25 hCG and derivatives as matrix metalloproteases inhibitors
DK97934545T DK0920330T3 (da) 1996-08-07 1997-07-25 hCG og derivater som inhibitorer af matrixmetalloproteaser
CA002262582A CA2262582C (en) 1996-08-07 1997-07-25 Hcg and derivatives as matrix metalloproteases inhibitors
IL128399A IL128399A (en) 1996-08-07 1997-07-25 hCG AND DERIVATIVES THEREOF IN THE PREPARATION OF MEDICAMENTS FOR INHIBITION OF MMP ENZYMATIC ACTIVITY
JP50755698A JP3996952B2 (ja) 1996-08-07 1997-07-25 マトリックスメタロプロテアーゼの阻害剤としてのｈＣＧおよびその誘導体
PT97934545T PT920330E (pt) 1996-08-07 1997-07-25 Hcg e derivados como inibidores de metaloproteases de matriz
PCT/EP1997/004053 WO1998005353A1 (en) 1996-08-07 1997-07-25 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
US09/242,099 US6444639B2 (en) 1996-08-07 1997-07-25 HCG and derivatives as matrix metalloproteases inhibitors
EP97934545A EP0920330B1 (en) 1996-08-07 1997-07-25 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
DE69717463T DE69717463T2 (de) 1996-08-07 1997-07-25 hCG UND DERIVATE ALS MATRIXMETALLOPROTEASE-INHIBITOREN
ES97934545T ES2183205T3 (es) 1996-08-07 1997-07-25 Hcg y derivados en calidad de inhibidores de melaloproteasas de la matriz.
ARP970103577A AR009013A1 (es) 1996-08-07 1997-08-06 Aplicacion de la hcg (gonadotrofinacorionica humana), subunidades beta, fragmentos activos y derivados de los mismos como inhibidores de las matricesde metaloproteinas y composiciones farmaceuticas que incluyen dichos inhibidores

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000566A IT1284876B1 (it) 1996-08-07 1996-08-07 Hcg come inibitore della collagenasi

Publications (3)

Publication Number Publication Date
ITRM960566A0 ITRM960566A0 (it) 1996-08-07
ITRM960566A1 ITRM960566A1 (it) 1998-02-07
IT1284876B1 true IT1284876B1 (it) 1998-05-22

Family

ID=11404385

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96RM000566A IT1284876B1 (it) 1996-08-07 1996-08-07 Hcg come inibitore della collagenasi

Country Status (14)

Country Link
US (1) US6444639B2 (it)
EP (1) EP0920330B1 (it)
JP (1) JP3996952B2 (it)
AR (1) AR009013A1 (it)
AT (1) ATE228372T1 (it)
AU (1) AU732972B2 (it)
CA (1) CA2262582C (it)
DE (1) DE69717463T2 (it)
DK (1) DK0920330T3 (it)
ES (1) ES2183205T3 (it)
IL (1) IL128399A (it)
IT (1) IT1284876B1 (it)
PT (1) PT920330E (it)
WO (1) WO1998005353A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
CA2556266A1 (en) 2004-02-13 2005-08-25 Stem Cell Therapeutics Corp. Use of luteinizing hormone (lh), and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
CA2582567A1 (en) 2004-10-07 2006-04-13 Stem Cell Therapeutics Corp. Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
WO2007106987A1 (en) 2006-03-17 2007-09-27 Stem Cell Therapeutics Corp. Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents
US20170136093A1 (en) * 2014-07-15 2017-05-18 Zietchick Research Institute, Llc Method for preventing or treating ocular disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250075B (it) 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US5677275A (en) * 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin
AU723646B2 (en) 1995-10-16 2000-08-31 Laboratoires Serono Sa Use of human chorionic gonadotropin in the treatment of Kaposi's Sarcoma
US5968513A (en) * 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin

Also Published As

Publication number Publication date
CA2262582A1 (en) 1998-02-12
DK0920330T3 (da) 2002-12-30
AU3771197A (en) 1998-02-25
US20010006940A1 (en) 2001-07-05
ITRM960566A0 (it) 1996-08-07
US6444639B2 (en) 2002-09-03
EP0920330B1 (en) 2002-11-27
DE69717463T2 (de) 2003-07-10
IL128399A (en) 2006-10-05
IL128399A0 (en) 2000-01-31
WO1998005353A1 (en) 1998-02-12
AR009013A1 (es) 2000-03-08
AU732972B2 (en) 2001-05-03
DE69717463D1 (de) 2003-01-09
ES2183205T3 (es) 2003-03-16
ATE228372T1 (de) 2002-12-15
JP2000516582A (ja) 2000-12-12
CA2262582C (en) 2009-02-24
JP3996952B2 (ja) 2007-10-24
ITRM960566A1 (it) 1998-02-07
EP0920330A1 (en) 1999-06-09
PT920330E (pt) 2003-02-28

Similar Documents

Publication Publication Date Title
ID18995A (id) Amida-amida inhibitor apo b-sekresi/mtp
DK1004669T3 (da) Hidtil ukendte differentieringsinhibitor
EE200000291A (et) 2-fenüülasendatud imidasotriasinoonid
ID23499A (id) Gestagen-gestagen non-steroidal
NO20000464D0 (no) Acykliske metalloprotease-inhibitorer
DE69805692D1 (de) Uhrenarmband
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
DE69625575D1 (de) Angiogense-Inhibitor
NO20002852L (no) Rørforbindelse
PT1047450E (pt) Combinacoes inibidor ace - inibidor mmp
FI942094A7 (fi) Kollagenaasin inhibiittori
FI973929A7 (fi) WOF inhibiittori
IT1284876B1 (it) Hcg come inibitore della collagenasi
NO983283D0 (no) Hydrokamsyre-baserte Kollagenase-inhibitorer
FR2722810B1 (fr) Toilettes biologiques
DE69828361D1 (de) Apoptose-inhibitor
NO20002965D0 (no) Antihyperlipidemisk statin-LP(a) inhibitor kombinasjoner
FR2758608B3 (fr) Perfectionnement a un projecteur
EP1007548A4 (en) THROMBIN INHIBITOR FROM TSE-TSE FLY
KR980004071U (ko) 조립식 가로등지주
IT1294261B1 (it) Perfezionamenti relativi a mezzi di illuminazione
KR970061065U (ko) 램프가 부설된 공책
ATE203827T1 (de) Immunoassay
IT1298565B1 (it) Nastro a piastre
KR970063226U (ko) 조명등

Legal Events

Date Code Title Description
0001 Granted